Physician profile
Gabor Matos
NPI 1639251747
$7,388.69
in general payments reported to CMS, 2019-2025
34 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $124 · 2021: $269 · 2022: $350 · 2023: $3,641 · 2024: $2,371 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,538 · Travel and Lodging: $2,783 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,538.25 |
| Travel and Lodging | $2,783.43 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,328.06 | 2023 | Angiovac, Alphavac |
| Inari Medical, INC. | $1,402.75 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $288.68 | 2021-2024 | Orsiro Mission |
| Boston Scientific Corporation | $263.37 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $251.22 | 2019-2023 | Xarelto |
| Pfizer INC. | $182.92 | 2022-2024 | |
| Shockwave Medical, INC | $170.63 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $166.99 | 2019-2024 | Esprit |
| Penumbra, INC. | $163.05 | 2021-2024 | Indigo System |
| Amgen INC. | $140.27 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $127.69 | 2019-2024 | |
| Medtronic, INC. | $100.99 | 2022-2024 | Azure Xt Dr Mri Surescan |
| Cardiovascular Systems INC. | $85.71 | 2019-2022 | |
| Cvrx, INC. | $80.32 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $76.85 | 2019-2025 | Farxiga |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $59.92 | 2019-2025 | Camzyos |
| W. L. Gore & Associates, INC. | $57.83 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Regeneron Healthcare Solutions, INC. | $54.47 | 2019-2025 | Evkeeza, Praluent |
| Abiomed | $53.94 | 2020-2021 | |
| Welch Allyn | $42.38 | 2019 | |
| Philips North America LLC | $40.46 | 2022-2023 | |
| Heartflow, INC. | $36.15 | 2024 | |
| Medtronic Vascular, INC. | $24.29 | 2020 | |
| Edwards Lifesciences Corporation | $23.85 | 2025 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $23.57 | 2025 | |
| Biosense Webster, INC. | $23.47 | 2023 | Carto 3 |
| Livanova USA, INC. | $20.15 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.65 | 2019 | |
| Recor Medical INC | $17.49 | 2024 | Paradise Renal Denervation System |
| Teleflex LLC | $16.87 | 2023 | Vascband |
| Scpharmaceuticals INC. | $16.47 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $15.28 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.95 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabor Matos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.